Global Substance Abuse Treatment Market - Snapshot

Substance abuse is the use of psychoactive substances, including alcohol and illicit drugs. Use of psychoactive substances can lead to dependence syndrome (a combination of behavioral, cognitive, and psychological phenomenon, which forces the individual to use alcohol, nicotine, and illicit drugs). However, expansion of the global substance abuse treatment market is expected to be hampered during the forecast period, owing to low awareness about addiction treatment products in developing countries and legal obligations for addiction treatment products.

substance abuse treatment market

The global substance abuse treatment market was valued at approximately US$ 8,000.0 Mn in 2017. It is anticipated to reach a value of nearly US$ 16,000 Mn by 2026, expanding at a CAGR of about 8% from 2018 to 2026. Awareness about initiatives by manufacturers and governments and rise in abuse of prescription drugs are likely to fuel the global substance abuse treatment market from 2018 to 2026.

Several unmet needs in the global substance abuse treatment market offer lucrative opportunities to existing players and new entrants, globally. Examples of recent developments in the field include submission of provisional patent application to the USPTO (United States Patent and Trademark Office) for proprietary pure cannabidiol compositions, by Normaco in October 2018, approval of SUBLOCADE, by the FDA, launched in the U.S. in March 2018, and U.S. FDA approval for the ANDA for methadone hydrochloride (5 mg and 10 mg) tablets for Glenmark Pharmaceuticals and its strategic partner Elite Pharmaceuticals, Inc in August 2018.

The global substance abuse treatment market has been extensively analyzed on the basis of the treatment type, distribution channel, and geography. Based on treatment type, the market has been classified into alcohol addiction treatment, nicotine addiction treatment, and drug abuse treatment. Furthermore, the alcohol treatment type segment has been sub-segmented into Acamprosate, Disulphirum, Naltrexone, and Benzodiazepine (BZD). Moreover, the nicotine addiction treatment segment has been further split into total NRT therapy, Varenicline, and Bupropion. The drug abuse treatment segment has been further sub-segmented into Methadone, Buprenorphine, and Naltexone. High market attractiveness of the drug abuse and nicotine addiction segments is due to the availability of different nicotine replacement products over-the-counter in order to combat tobacco and nicotine addiction and the increase in adoption of prescription opioids or illicit drugs. Multiple side-effects associated with the use of methadone and innovations in other types of drugs that are used for addiction treatment hamper the use of methadone. On the other hand, availability of innovative buprenorphine products in the form of pills, sublingual films, and implants is improving the treatment methods, thereby boosting the buprenorphine sub-segment during the forecast period.

Furthermore, in terms of distribution channel, the global substance abuse treatment market has been categorized into hospital pharmacies, retail pharmacies and drug stores, and others (online sales). Expansion of the hospital pharmacies segment can be attributed to the rise in prescription filling at hospital pharmacies, availability of certified physicians in hospital pharmacies, advice for use of the drugs from certified physicians, and authenticity of quality and price of medicines.

North America (NA) accounted for a prominent share of the global substance abuse treatment market in 2017, followed by Europe. Rise in awareness regarding opioid treatment programs and increase in government initiatives to raise awareness about substance abuse, ill-effects of drugs, and the importance of abuse treatment are key factors propelling the substance abuse treatment market in North America. In Europe, drug addiction treatment is supported by government and private bodies with a diverse range of interventions. Additionally, the provision of outpatient treatment and support for treatment programs have increased considerably since the beginning of 2010. Moreover, government initiatives to spread awareness about the increasing use of cannabis and its negative effects are expected to drive the substance abuse treatment market in Europe.

The substance abuse market in Asia Pacific region is anticipated to expand at a notable CAGR during the forecast period. Several countries in Asia Pacific are taking prominent initiatives to address issues related to drug abuse. Additionally, various government bodies are spending significant amounts of money to promote awareness about the prevention and treatment of drug addiction. For instance, in 2015, the Federal Government of Australia spent US$ 300 Mn to improve treatment methods for ice or crystal methamphetamine addiction. Lack of stringent medical regulatory standards for prescription drugs and low awareness about substance abuse are likely to hamper the substance abuse treatment market in Latin America and Middle East & Africa during the forecast period. 

Key companies operating in the global substance abuse treatment market and profiled in the report include Alkermes, Allergan PLC, Indivior PLC, Noramco (part of SK Capital Partners), Teva Pharmaceutical Industries Ltd, Pfizer, Inc., GlaxoSmithKline plc, Mallinckrodt plc, BioCorRx, Inc., and Glenmark Pharmaceuticals Ltd.

Increasing Number of Drug Abuse Cases on the Back of COVID-19 to Boost the Growth of the Substance Abuse Treatment Market

The consumption of alcohol, cigarettes, and drugs are on a rapid rise across the globe. The increasing use of nicotine and other addictive substances has risen significantly due to the stressful lifestyle of a large number of individuals across the world.

  • To tackle this problem, many awareness campaigns and initiatives are being organized by government and non-government organizations. Based on all these aspects, the global substance abuse treatment market is extrapolated to gain substantial growth across the assessment period of 2018-2026.
  • Substance abuse can be defined as the use of psychoactive substances in large quantities. Substance abuse treatment is a type of treatment offered to the patient for reducing drug craving and flushing out drugs or alcohol from the body. The inclination of many individuals to live a drug-free and healthy life is pushing the substance abuse treatment market toward growth.
  • Government bodies of various countries are trying to reduce the drug menace among their citizens. Formation of special committees, conducting awareness drives, designing novel initiatives for reducing substance abuse are some of the important factors that will directly or indirectly influence the growth of the substance abuse treatment market.
  • Underdeveloped economies observe a larger number of substance abuse cases due to the lack of awareness among the individuals regarding the treatment options. Manufacturers in the substance abuse treatment market are focusing on generating awareness among these countries to increase their influence. Such developments lay a red carpet of growth.
  • The COVID-19 outbreak has led to an increase in substance abuse due to heightened stress levels. Fear of job loss, financial insecurities, and instability are some vital factors that have accelerated substance abuse. This factor will help in propelling the growth of the substance abuse treatment market. Healthcare services and drug production were allowed to function during the strict lockdown period. Hence, the substance abuse treatment market has not been impacted much due to the pandemic.

Global Substance Abuse Treatment Market: Overview 

Substance abuse is use of psychoactive substances, including alcohol and illicit drugs. Use of psychoactive substances can lead to dependence syndrome (a combination of behavioral, cognitive, and psychological phenomenon, which forces the individual to use alcohol, nicotine, and illicit drugs). Awareness about initiatives by manufacturers and governments and rise in abuse of prescription drugs are likely to fuel the global substance abuse treatment market from 2018 to 2026.

The global substance abuse treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment type, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global substance abuse treatment market. 

Global Substance Abuse Treatment Market: Key Segments 

The report offers detailed segmentation of the global substance abuse treatment market. Based on treatment type, the global substance abuse treatment market has been classified into alcohol addiction treatment, nicotine addiction treatment, and drug abuse treatment.  The alcohol addiction treatment segment is likely to expand at a prominent growth rate during the forecast period, due to increasing consumption of alcohol worldwide, rising use of medicines for restriction of alcohol consumption, and relatively lower cost per prescription for these medicines. The duration of action is also an important driver of the segment. 

On the other hand, expansion of the drug abuse treatment segment is attributed to a rise in the usage of prescription drugs/illicit drugs, increase in the number of deaths from excessive use of prescription drugs, and a surge in research & development by leading pharmaceutical companies. 

In terms of distribution channel, the global substance abuse treatment market has been categorized into hospital pharmacies, retail pharmacies and drug stores, and others (online sales). Expansion of the segment can be attributed to the rise in prescription filling at hospital pharmacies, availability of certified physicians in hospital pharmacies, advice for use of the drugs from certified physicians, and authenticity of quality and price of medicines. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. 

Global Substance Abuse Treatment Market: Regional Outlook

In terms of region, the global substance abuse treatment market has been segmented into five major regions and the key countries in the respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries and Rest of Middle East & Africa ). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the global substance abuse treatment market are Alkermes, Allergan PLC, Indivior PLC, Noramco (part of SK Capital Partners), and Teva Pharmaceutical Industries Ltd. Other players include Pfizer, Inc., GlaxoSmithKline plc, Mallinckrodt plc, BioCorRx, Inc., and Glenmark Pharmaceuticals Ltd.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global substance abuse treatment market has been segmented as follows:

Treatment Type

  • Drug Abuse Treatment
    • Methadone
    • Buprenorphine
    • Naltexone
  • Nicotine Addiction Treatment
    • Total NRT therapy
    • Varenicline
    • Bupropion
  • Alcohol Addiction Treatment
    • Acamprosate
    • Disulphirum
    • Naltrexone
    • Benzodiazepines (BZD)

 Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies and Drug Stores
  • Others (Online Sales) 

Region

  • North America
    • U.S.
    • Canada  
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe  
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific  
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America  
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa 

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights
     1.3. Assumptions and Acronyms Used

2. Research Methodology 

3. Executive Summary

4. Market Overview
     4.1. Introduction
     4.2. Key Industry Evolution/Developments
     4.3. Market Dynamics
           4.3.1. Drivers
                    4.3.1.1. Awareness about Initiatives by Manufacturers and Governments 
                    4.3.1.2. Favorable Reimbursements for Smoking Cessation Therapy and Growth in the Number of Private Insurance Players
                    4.3.1.3. Surge in Disposable Income
                    4.3.1.4. Growing Abuse of Prescription Drugs 
           4.3.2. Restraints
                    4.3.2.1. Low Awareness about Addiction Treatment Products in Developing Countries
                    4.3.2.2. Legal Obligations for Addiction Treatment Products
           4.3.3. Opportunities
                    4.3.3.1. Research and Development
                    4.3.3.2. Introduction of New Products
           4.3.4. Trends 
                    4.3.4.1. Rise in Mergers and Acquisitions in the Industry
                    4.3.4.2. Government Initiatives and Funding
     4.4. Global Substance Abuse Treatment Market Forecast
     4.5. Porter’s Five Forces
     4.6. Pipeline Analysis 
     4.7. Porter’s Five Forces
     4.8. Key Mergers and Acquisitions
     4.9. Regulatory Scenario

5. Global Substance Abuse Treatment Market, by Treatment Type
     5.1. Introduction and Definitions 
     5.2. Key Findings
     5.3. Global Substance Abuse Treatment Market Analysis, by Treatment Type
     5.4. Global Substance Abuse Treatment Market Forecast, by Treatment Type
           5.4.1. Alcohol Addiction Treatment
                    5.4.1.1. Acamprosate; 
                    5.4.1.2. Disulphirum; 
                    5.4.1.3. Naltrexone; 
                    5.4.1.4. Benzodiazepines Wound Care Devices
           5.4.2. Nicotine Addiction Treatment
                    5.4.2.1. Total NRT therapy ; 
                    5.4.2.2. Varenicline; 
                    5.4.2.3. Bupropion 
           5.4.3. Drug Abuse Treatment
                    5.4.3.1. Methadone; 
                    5.4.3.2. Buprenorphine; 
                    5.4.3.3. Naltexone
     5.5. Global Substance Abuse Treatment Market Attractiveness Analysis, by Treatment Type

6. Global Substance Abuse Treatment Market Analysis and Forecast, by Distribution Channel
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Substance Abuse Treatment Market Value Forecast, by Distribution Channel, 2016–2026 
           6.3.1. Hospital Pharmacies; 
           6.3.2. Retail Pharmacies and Drug Stores; 
           6.3.3. Others (Online Sales)
     6.4. Global Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel 

7. Global Substance Abuse Treatment Market Analysis and Forecast, by Region
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Substance Abuse Treatment Market Value Forecast, by End-user, 2016–2026 
           7.3.1. North America 
           7.3.2. Europe 
           7.3.3. Asia-Pacific 
           7.3.4. Latin America
           7.3.5. Middle East & Africa 
     7.4. Global Substance Abuse Treatment Market Attractiveness Analysis, by Region 

8. North America Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     8.1. Key Findings
     8.2. North America Substance Abuse Treatment Market Overview
     8.3. North America Substance Abuse Treatment Market Value Share Analysis, by Country
     8.4. North America Substance Abuse Treatment Market Size and Forecast, by Country
           8.4.1. U.S.
           8.4.2. Canada
     8.5. North America Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     8.6. North America Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           8.6.1. Alcohol Addiction Treatment
                    8.6.1.1. Acamprosate; 
                    8.6.1.2. Disulphirum; 
                    8.6.1.3. Naltrexone; 
                    8.6.1.4. Benzodiazepines
           8.6.2. Nicotine Addiction Treatment
                    8.6.2.1. Total NRT therapy ; 
                    8.6.2.2. Varenicline; 
                    8.6.2.3. Bupropion 
           8.6.3. Drug Abuse Treatment
                    8.6.3.1. Methadone; 
                    8.6.3.2. Buprenorphine; 
                    8.6.3.3. Naltexone
     8.7. North America Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     8.8. North America Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           8.8.1. Hospital Pharmacies; 
           8.8.2. Retail Pharmacies and Drug Stores; 
           8.8.3. Others (Online Sales)
     8.9. North America Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           8.9.1. By Treatment Type
           8.9.2. By Distribution Channel
           8.9.3. By Country 

9. Europe Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     9.1. Key Findings
     9.2. Europe Substance Abuse Treatment Market Overview
     9.3. Europe Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     9.4. Europe Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           9.4.1. Germany
           9.4.2. France
           9.4.3. U.K.
           9.4.4. Spain
           9.4.5. Italy
           9.4.6. Russia
           9.4.7. Rest of Europe
     9.5. Europe Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     9.6. Europe Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           9.6.1. Alcohol Addiction Treatment
                    9.6.1.1. Acamprosate; 
                    9.6.1.2. Disulphirum; 
                    9.6.1.3. Naltrexone; 
                    9.6.1.4. Benzodiazepines 
           9.6.2. Nicotine Addiction Treatment
                    9.6.2.1. Total NRT therapy ; 
                    9.6.2.2. Varenicline; 
                    9.6.2.3. Bupropion 
           9.6.3. Drug Abuse Treatment
                    9.6.3.1. Methadone; 
                    9.6.3.2. Buprenorphine; 
                    9.6.3.3. Naltexone
     9.7. Europe Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     9.8. Europe Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           9.8.1. Hospital Pharmacies; 
           9.8.2. Retail Pharmacies and Drug Stores; 
           9.8.3. Others (Online Sales)
     9.9. Europe Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           9.9.1. By Treatment Type
           9.9.2. By Distribution Channel
           9.9.3. By Country/Sub-region 

10. Asia Pacific Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     10.1. Key Findings
     10.2. Asia Pacific Substance Abuse Treatment Market Overview
     10.3. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     10.4. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           10.4.1. China
           10.4.2. Japan
           10.4.3. India
           10.4.4. Australia & New Zealand
           10.4.5. Rest of Asia Pacific 
     10.5. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     10.6. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           10.6.1. Alcohol Addiction Treatment
                    10.6.1.1. Acamprosate; 
                    10.6.1.2. Disulphirum; 
                    10.6.1.3. Naltrexone; 
                    10.6.1.4. Benzodiazepines 
           10.6.2. Nicotine Addiction Treatment
                    10.6.2.1. Total NRT therapy ; 
                    10.6.2.2. Varenicline; 
                    10.6.2.3. Bupropion 
           10.6.3. Drug Abuse Treatment
                    10.6.3.1. Methadone; 
                    10.6.3.2. Buprenorphine; 
                    10.6.3.3. Naltexone
     10.7. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     10.8. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           10.8.1. Hospital Pharmacies; 
           10.8.2. Retail Pharmacies and Drug Stores; 
           10.8.3. Others (Online Sales)
     10.9. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           10.9.1. By Treatment Type
           10.9.2. By Distribution Channel
           10.9.3. By Country/Sub-region 

11. Latin America Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     11.1. Key Findings
     11.2. Latin America Substance Abuse Treatment Market Overview
     11.3. Latin America Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     11.4. Latin America Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           11.4.1. Brazil
           11.4.2. Mexico
           11.4.3. Rest of Latin America 
     11.5. Latin America Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     11.6. Latin America Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           11.6.1. Alcohol Addiction Treatment
                    11.6.1.1. Acamprosate; 
                    11.6.1.2. Disulphirum; 
                    11.6.1.3. Naltrexone; 
                    11.6.1.4. Benzodiazepines 
           11.6.2. Nicotine Addiction Treatment
                    11.6.2.1. Total NRT therapy ; 
                    11.6.2.2. Varenicline; 
                    11.6.2.3. Bupropion 
           11.6.3. Drug Abuse Treatment
                    11.6.3.1. Methadone; 
                    11.6.3.2. Buprenorphine; 
                    11.6.3.3. Naltexone
     11.7. Latin America Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     11.8. Latin America Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           11.8.1. Hospital Pharmacies; 
           11.8.2. Retail Pharmacies and Drug Stores; 
           11.8.3. Others (Online Sales)
     11.9. Latin America Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           11.9.1. By Treatment Type
           11.9.2. By Distribution Channel
           11.9.3. By Country/Sub-region 

12. Middle East & Africa Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     12.1. Key Findings
     12.2. Middle East & Africa Substance Abuse Treatment Market Overview
     12.3. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     12.4. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           12.4.1. South Africa
           12.4.2. GCC
           12.4.3. Israel
           12.4.4. Rest of Middle East & Africa 
     12.5. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     12.6. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           12.6.1. Alcohol Addiction Treatment
                    12.6.1.1. Acamprosate; 
                    12.6.1.2. Disulphirum; 
                    12.6.1.3. Naltrexone; 
                    12.6.1.4. Benzodiazepines 
           12.6.2. Nicotine Addiction Treatment
                    12.6.2.1. Total NRT therapy ; 
                    12.6.2.2. Varenicline; 
                    12.6.2.3. Bupropion 
           12.6.3. Drug Abuse Treatment
                    12.6.3.1. Methadone; 
                    12.6.3.2. Buprenorphine; 
                    12.6.3.3. Naltexone
     12.7. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     12.8. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           12.8.1. Hospital Pharmacies; 
           12.8.2. Retail Pharmacies and Drug Stores; 
           12.8.3. Others (Online Sales)
     12.9. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           12.9.1. By Treatment Type
           12.9.2. By Distribution Channel
           12.9.3. By Country/Sub-region 

13. Competitive Landscape
     13.1. Competition Metrix
     13.2. Company Share
     13.3. Market Footprint Analysis 
     13.4. Company Profiles
           13.4.1. Alkermes 
                    13.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.1.2. Financial Overview 
                    13.4.1.3. Product Portfolio
                    13.4.1.4. SWOT Analysis
                    13.4.1.5. Strategic Overview
           13.4.2. Allergan PLC, 
                    13.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.2.2. Financial Overview 
                    13.4.2.3. Product Portfolio
                    13.4.2.4. SWOT Analysis
                    13.4.2.5. Strategic Overview
           13.4.3. Indivior PLC,
                    13.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.3.2. Financial Overview 
                    13.4.3.3. Product Portfolio
                    13.4.3.4. SWOT Analysis
                    13.4.3.5. Strategic Overview
           13.4.4. Noramco (part of SK Capital Partners), 
                    13.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.4.2. Financial Overview 
                    13.4.4.3. Product Portfolio
                    13.4.4.4. SWOT Analysis
                    13.4.4.5. Strategic Overview
           13.4.5. Teva Pharmaceutical Industries Ltd,
                    13.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.5.2. Financial Overview 
                    13.4.5.3. Product Portfolio
                    13.4.5.4. SWOT Analysis
                    13.4.5.5. Strategic Overview
           13.4.6. Pfizer, Inc, 
                    13.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.6.2. Financial Overview 
                    13.4.6.3. Product Portfolio
                    13.4.6.4. SWOT Analysis
                    13.4.6.5. Strategic Overview
           13.4.7. GlaxoSmithKline plc, 
                    13.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.7.2. Financial Overview 
                    13.4.7.3. Product Portfolio
                    13.4.7.4. SWOT Analysis
                    13.4.7.5. Strategic Overview
           13.4.8. Mallinckrodt plc, 
                    13.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.8.2. Financial Overview 
                    13.4.8.3. Product Portfolio
                    13.4.8.4. SWOT Analysis
                    13.4.8.5. Strategic Overview
           13.4.9. BioCorRx, Inc., 
                    13.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.9.2. Financial Overview 
                    13.4.9.3. Product Portfolio
                    13.4.9.4. SWOT Analysis
                    13.4.9.5. Strategic Overview
           13.4.10. Glenmark Pharmaceuticals Ltd 
                    13.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.10.2. Financial Overview 
                    13.4.10.3. Product Portfolio
                    13.4.10.4. SWOT Analysis
                    13.4.10.5. Strategic Overview
     13.5. Competitive Business Strategies 

List of Tables 

Table 1: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 2: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment,
Table 3: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment,
Table 4: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 6: Global Substance Abuse Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 7: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 8: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 9: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 10: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 11: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,
Table 12: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 14: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment,
Table 15: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 16: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 17: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 18: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 19: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 20: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 21: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 22: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment,
Table 23: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,
Table 24: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 26: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 27: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 28: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 29: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 30: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,
Table 31: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 32: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 33: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 34: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 35: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 36: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

List of Figures

Figure 1: Global Substance Abuse Treatment Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 2: Global Substance Abuse Treatment Market Value (US$ Mn), by Treatment Type, 2017
Figure 3: Global Substance Abuse Treatment Market Value (US$ Mn), by Distribution Channel, 2017
Figure 4: Global Substance Abuse Treatment Market Opportunity Map, by Treatment Type 
Figure 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 6: Global Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 7: Global Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 8: Alcohol Addiction Treatment Segment, 2016–2026
Figure 9: Nicotine Addiction Treatment Segment, 2016–2026
Figure 10: Drug Abuse Treatment Segment, 2016–2026
Figure 11: Global Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 12: Global Substance Abuse Treatment Market Attractiveness, by Alcohol Addiction Treatment, 2018-2026
Figure 13: By Acamprosate Sub-segment, 2016–2026
Figure 14: By Disulphirum Sub-segment, 2016–2026
Figure 15: By Naltrexone Sub-segment, 2016–2026
Figure 16: By Benzodiazepine (BZD) Sub-segment, 2016–2026
Figure 17: Global Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 18: Global Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 19: by Total NRT Therapy Segment, 2016–2026
Figure 20: by Varenicline Segment, 2016–2026
Figure 21: by Bupropion Segment, 2016–2026
Figure 22: Global Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 23: Global Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 24: By Methadone Segment, 2016–2026
Figure 25: by Buprenorphine Segment, 2016–2026
Figure 26: by Naltexone Segment, 2016–2026
Figure 27: Global Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 28: Global Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 29: By Hospital Pharmacies Segment, 2016–2026
Figure 30: by Retail Pharmacies and Drug Stores Segment, 2016–2026
Figure 31: by Others (Online Sales) Segment, 2016–2026
Figure 32: Global Substance Abuse Treatment Market Attractiveness, by Region, 2018 and 2026
Figure 33: North America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
Figure 34: North America Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 35: North America Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 36: North America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 37: North America Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 38: North America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 39: North America Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 40: North America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 41: North America Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 42: North America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 43: North America Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 44: North America Substance Abuse Treatment Market Value Share, by Country, 2017 and 2026
Figure 45: North America Substance Abuse Treatment Market Attractiveness, by Country, 2018–2026
Figure 46: Europe Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
Figure 47: Europe Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 48: Europe Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 49: Europe Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 50: Europe Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 51: Europe Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 52: Europe Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 53: Europe Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 54: Europe Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 55: Europe Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 56: Europe Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 57: Europe Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 58: Europe Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 59: Asia Pacific Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
Figure 60: Asia Pacific Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 61: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 62: Asia Pacific Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 63: Asia Pacific Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 64: Asia Pacific Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 65: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 66: Asia Pacific Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 67: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 68: Asia Pacific Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 69: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 70: Asia Pacific Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 71: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 72: Latin America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Treatment Type, 2016 and 2026
Figure 73: Latin America Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 74: Latin America Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 75: Latin America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 76: Latin America Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 77: Latin America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 78: Latin America Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 79: Latin America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 80: Latin America Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 81: Latin America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 82: Latin America Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 83: Latin America Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 84: Latin America Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 85: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 86: Middle East & Africa Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 87: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 88: Middle East & Africa Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 89: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Alcohol Addiction Treatment, 2018–2026
Figure 90: Middle East & Africa Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 91: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment,
Figure 92: Middle East & Africa Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 93: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 94: Middle East & Africa Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 95: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 96: Middle East & Africa Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 97: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Substance Abuse Treatment Market